A novel PKC activating molecule promotes neuroblast differentiation and delivery of newborn neurons in brain injuries
Authors:
- Samuel Domínguez-GarcíaSamuel Domínguez-García
- Noelia Geribaldi-DoldánNoelia Geribaldi-Doldán
- Ricardo Gómez-OlivaRicardo Gómez-Oliva
- Felix A. RuizFelix A. Ruiz
- Livia CarrascalLivia Carrascal
- Jorge BolívarJorge Bolívar
- Cristina VerásteguiCristina Verástegui
- Antonio J. Macías-SánchezAntonio J. Macías-Sánchez
- Rosario Hernández-GalánRosario Hernández-Galán
- Pedro Nunez-AbadesPedro Nunez-Abades
- Carmen CastroCarmen Castro
Open Access
- 22 April 2020
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 11 (4) , 1-19
Abstract
Neural stem cells are activated within neurogenic niches in response to brain injuries. This results in the production of neuroblasts, which unsuccessfully attempt to migrate toward the damaged tissue. Injuries constitute a gliogenic/non-neurogenic niche generated by the presence of anti-neurogenic signals, which impair neuronal differentiation and migration. Kinases of the protein kinase C (PKC) family mediate the release of growth factors that participate in different steps of the neurogenic process, particularly, novel PKC isozymes facilitate the release of the neurogenic growth factor neuregulin. We have demonstrated herein that a plant derived diterpene, (EOF2; CAS number 2230806-06-9), with the capacity to activate PKC facilitates the release of neuregulin 1, and promotes neuroblasts differentiation and survival in cultures of subventricular zone (SVZ) isolated cells in a novel PKC dependent manner. Local infusion of this compound in mechanical cortical injuries induces neuroblast enrichment within the perilesional area, and noninvasive intranasal administration of EOF2 promotes migration of neuroblasts from the SVZ towards the injury, allowing their survival and differentiation into mature neurons, being some of them cholinergic and GABAergic. Our results elucidate the mechanism of EOF2 promoting neurogenesis in injuries and highlight the role of novel PKC isozymes as targets in brain injury regeneration.Keywords
This publication has 50 references indexed in Scilit:
- ADAM-17/Tumor Necrosis Factor-α-Converting Enzyme Inhibits Neurogenesis and Promotes Gliogenesis from Neural Stem CellsStem Cells, 2011
- Galectin-3 maintains cell motility from the subventricular zone to the olfactory bulbJournal of Cell Science, 2011
- Epidermal Growth Factor (EGF) Ligand Release by Substrate-specific A Disintegrin and Metalloproteases (ADAMs) Involves Different Protein Kinase C (PKC) Isoenzymes Depending on the StimulusJournal of Biological Chemistry, 2011
- Guidelines for reporting experiments involving animals: the ARRIVE guidelinesBritish Journal of Pharmacology, 2010
- Animal research: Reporting in vivo experiments: The ARRIVE guidelinesBritish Journal of Pharmacology, 2010
- Adult Mouse Subventricular Zone Stem and Progenitor Cells Are Sessile and Epidermal Growth Factor Receptor Negatively Regulates Neuroblast MigrationPLOS ONE, 2009
- Awake Intranasal Insulin Delivery Modifies Protein Complexes and Alters Memory, Anxiety, and Olfactory BehaviorsJournal of Neuroscience, 2009
- Epidermal Growth Factor Induces the Progeny of Subventricular Zone Type B Cells to Migrate and Differentiate into OligodendrocytesStem Cells, 2009
- Origin and progeny of reactive gliosis: A source of multipotent cells in the injured brainProceedings of the National Academy of Sciences, 2008
- Nitric Oxide Decreases Subventricular Zone Stem Cell Proliferation by Inhibition of Epidermal Growth Factor Receptor and Phosphoinositide-3-Kinase/Akt PathwayStem Cells, 2006